Electrostatics of pharmaceutical aerosols for inhalation is a relatively new research area. Particle charges have been proposed to potentially influence deposition in the lungs but no conclusive in vivo data have been reported. Investigation of the relationship between the formulation and aerosol charging is required to further explore this area. The modified electrical low pressure impactor (E...

INTRODUCTION It has been argued that tapentadol may pharmacologically have lower abuse potential than other pharmaceutical opioids currently available. However, there has been no comprehensive triangulation of data regarding use and harms associated with this formulation. A sustained-release formulation (SRF) of tapentadol (Palexia) was released in Australia in 2011 and listed for public subsid...

One of the most significant issues in pharmaceutical industries, prior to commercializationof a pharmaceutical preparation is the “preformulation” stage. However, far too attention hasbeen paid to verification of the software assisted statistical designs in preformulation studies.The main aim of this study was to report a step by step preformulation approach for a semisolidpreparation based on ...

The poor water solubility of drugs is major problem for drug formulation. To date, nanoscale systems for drug delivery have gained much interest as a way to improve the solubility problems. The reduction of drug particles into the sub-micron range leads to a significant increase in the dissolution rate and therefore enhances bioavailability. Nanosuspensions are promising candidates that can be ...

BCS class II drugs pose challenging problems in their pharmaceutical product development process because of their low solubility and dissolution rates. They require enhancement in solubility and dissolution rate in their formulation development especially solid dosage forms such as tablets and capsules. Several conventional methods and new emerging technologies have been developed for formulati...